Below is an image of an Eli Lilly letter which informs doctors in the UK that Prozac is no longer authorized for use in (so-called) premenstrual dysphoric disorder (PMDD). For a larger view, please click on the image.
Walk-in Drug Trial Clinic NYC Upper East Side Wed, 17 Sep 2003 While ethics is currently a hot topic at universities, and ethics committees and conferences have become a growth industry within the research community, ethics has not affected the increasing commercialization of medicine and clinical trials. Dr. Ronald Fieve,…
Brainstorm to Breakthrough: A Surgical Procedure is Born – NYT Mon, 4 Aug 2003 Two contrasting reports about experimental surgical procedures: The New York Times reports about a breakthrough surgical procedure to lengthen the intestine in babies born with an intestine so short it is dysfunctional and they are at…
Foster Care Study – Editorial NY Times Thu, 19 May 2005 A major study funded by 3 states and the William T. Grant Foundation, confirms that America’s foster care system is dismal and that children who “graduate” at 18, haven’t been properly schooled – most haven’t finished High School: “As…
UK issues ban on second SSRI antidepressant for children Sun, 21 Sep 2003 The UK Observer reports (below) that although antidepressant drugs of the SSRI class have not been approved for children, last year doctors (who are unaware of the severe risks associated with SSRIs) wrote 170,000 prescriptions of antidepressants…
Fast growing business: Unethical clinical trials in India – Asia Times Tue, 27 Jul 2004 Asia Times reports: “India increasingly emerges as a preferred destination for outsourcing clinical trials – testing of new drugs on humans – the country may also be heading toward providing the greatest source of human…
According to a report by the Associated Press, the FDA has approved expanded use of Merck’s toxic antipsychotic drug, Saphris, for treating acute manic-depressive behavior in adults. Antipsychotics (neuroleptics) are a controversial class of drugs: Risperdal (approved in 1993), Zyprexa (1994), Seroquel (1997), Abilify (2002), and Saphris (2009). These drugs’…
